Streetsweeper takes another shot at Unilife

|About: Unilife Corporation (UNIS)|By:, SA News Editor

Building on a bearish SA piece by Kerrisdale Capital, StreetSweeper adds additional red flags: 1) An FDA report mentioning "recurring systemic issues" and noting "concern over the firm's promotional materials 2) Reality consistently falling short of management boasts 3) A lawsuit by a fired former VP has not been dismissed, according to the plaintiffs attorney, and more.

"Pre-filled syringe company Unilife (UNIS -3%) is losing millions and management is handing investors a minus 190% return on their money ... But its executives are living like kings," writes the StreetSweeper's Sonya Colberg.